PCRX Investors: Take Action in Leading the Pacira Biosciences Inc. Securities Fraud Lawsuit
Rosen Law Firm Issues Important Reminder to Pacira BioSciences, Inc. Investors What You Need to Know In a recent press release, Rosen Law Firm, a global investor rights law firm, issued a reminder to purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) regarding the important lead plaintiff deadline of March 14, 2025. The Class…